Constitutional rearrangement of the architectural factor HMGA2: a novel human phenotype including overgrowth and lipomas.

Although somatic mutations in a number of genes have been associated with development of human tumors, such as lipomas, relatively few examples exist of germline mutations in these genes. Here we describe an 8-year-old boy who has a de novo pericentric inversion of chromosome 12, with breakpoints at p11.22 and q14.3, and a phenotype including extreme somatic overgrowth, advanced endochondral bone and dental ages, a cerebellar tumor, and multiple lipomas. His chromosomal inversion was found to truncate HMGA2, a gene that encodes an architectural factor involved in the etiology of many benign mesenchymal tumors and that maps to the 12q14.3 breakpoint. Similar truncations of murine Hmga2 in transgenic mice result in somatic overgrowth and, in particular, increased abundance of fat and lipomas, features strikingly similar to those observed in the child. This represents the first report of a constitutional rearrangement affecting HMGA2 and demonstrates the role of this gene in human growth and development. Systematic genetic analysis and clinical studies of this child may offer unique insights into the role of HMGA2 in adipogenesis, osteogenesis, and general growth control.

[1]  D. McGee,et al.  Cytogenetic profile of 109 lipomas. , 1991, Cancer research.

[2]  C. Cremers,et al.  Identification of a hot spot for microdeletions in patients with X-linked deafness type 3 (DFN3) 900 kb proximal to the DFN3 gene POU3F4. , 1996, Human molecular genetics.

[3]  S. Kwok,et al.  Molecular cloning, expression, localization, and gene organization of PTX1, a human nuclear protein that is downregulated in prostate cancer. , 2001, DNA and cell biology.

[4]  H. Horvitz,et al.  Novel cysteine-rich motif and homeodomain in the product of the Caenorhabditis elegans cell lineage gene lin-II , 1990, Nature.

[5]  N. Zanesi,et al.  HMGA2 locus rearrangement in a case of acute lymphoblastic leukemia. , 2003, International journal of oncology.

[6]  J. Mark,et al.  Cytogenetic and molecular observations in human and experimental salivary gland tumors. , 1990, Cancer genetics and cytogenetics.

[7]  S. Orkin,et al.  Purification of the human NF-E2 complex: cDNA cloning of the hematopoietic cell-specific subunit and evidence for an associated partner , 1993, Molecular and cellular biology.

[8]  Xianjin Zhou,et al.  Mutation responsible for the mouse pygmy phenotype in the developmentally regulated factor HMGI-C , 1995, Nature.

[9]  Herman Van den Berghe,et al.  Recurrent rearrangements in the high mobility group protein gene, HMGI-C, in benign mesenchymal tumours , 1995, Nature Genetics.

[10]  G. Chiappetta,et al.  A 12q13 translocation involving the HMGI-C gene in richter transformation of a chronic lymphocytic leukemia. , 2000, Cancer genetics and cytogenetics.

[11]  J. Bullerdiek,et al.  Intron 3 of HMGIC is the most frequent target of chromosomal aberrations in human tumors and has been conserved basically for at least 30 million years. , 1998, Cancer genetics and cytogenetics.

[12]  K. Chada,et al.  In vivo modulation of Hmgic reduces obesity , 2000, Nature Genetics.

[13]  P. Rogalla,et al.  HMGI-C, a member of the high mobility group family of proteins, is expressed in hematopoietic stem cells and in leukemic cells. , 1997, Leukemia & lymphoma.

[14]  C. Ladd,et al.  Fusion transcripts involving HMGA2 are not a common molecular mechanism in uterine leiomyomata with rearrangements in 12q15. , 2003, Cancer research.

[15]  J. Fletcher,et al.  Identification of a YAC spanning the translocation breakpoints in uterine leiomyomata, pulmonary chondroid hamartoma, and lipoma: physical mapping of the 12q14-q15 breakpoint region in uterine leiomyomata. , 1995, Genomics.

[16]  H. Kronenberg,et al.  The chondrogenic transcription factor Sox9 is a target of signaling by the parathyroid hormone-related peptide in the growth plate of endochondral bones. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[17]  A. Rydholm,et al.  Fusion, Disruption, and Expression of HMGA2 in Bone and Soft Tissue Chondromas , 2003, Modern Pathology.

[18]  J Glowacki,et al.  Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone-related peptide gene. , 1994, Genes & development.

[19]  Charis Eng,et al.  PTEN: One Gene, Many Syndromes , 2003, Human mutation.

[20]  S. Toksvig-Larsen,et al.  The Tumor-Associated Gene HMGIC Is Expressed in Normal and Osteoarthritis-Affected Synovia , 2001, Modern Pathology.

[21]  J. Fletcher,et al.  Disruption of the architectural factor HMGI-C: DNA-binding AT hook motifs fused in lipomas to distinct transcriptional regulatory domains , 1995, Cell.

[22]  Santa Jeremy Ono,et al.  Transgenic Mice Expressing a Truncated Form of the High Mobility Group I-C Protein Develop Adiposity and an Abnormally High Prevalence of Lipomas* , 2000, The Journal of Biological Chemistry.

[23]  C. Morton,et al.  HMGIC expression in human adult and fetal tissues and in uterine leiomyomata , 1999, Genes, chromosomes & cancer.

[24]  J. Haubrich,et al.  Cytogenetic subtyping of 220 salivary gland pleomorphic adenomas: correlation to occurrence, histological subtype, and in vitro cellular behavior. , 1993, Cancer genetics and cytogenetics.

[25]  R. Reeves,et al.  HMGI/Y proteins: flexible regulators of transcription and chromatin structure. , 2001, Biochimica et biophysica acta.

[26]  C. Croce,et al.  Role of the high mobility group A proteins in human lipomas. , 2001, Carcinogenesis.

[27]  E. Birney,et al.  Comparison of human chromosome 21 conserved nongenic sequences (CNGs) with the mouse and dog genomes shows that their selective constraint is independent of their genic environment. , 2004, Genome research.

[28]  K. Chada,et al.  HMGA2 is expressed in an allele-specific manner in human lipomas. , 2003, Cancer genetics and cytogenetics.

[29]  C. Croce,et al.  The expression of a truncated HMGI-C gene induces gigantism associated with lipomatosis. , 1999, Cancer research.

[30]  F. Bauters,et al.  Dysregulation and overexpression of HMGA2 in myelofibrosis with myeloid metaplasia , 2004, Genes, chromosomes & cancer.

[31]  Alexandre Reymond,et al.  Evolutionary Discrimination of Mammalian Conserved Non-Genic Sequences (CNGs) , 2003, Science.

[32]  G. Viglietto,et al.  Truncated and chimeric HMGI-C genes induce neoplastic transformation of NIH3T3 murine fibroblasts , 1998, Oncogene.

[33]  B. Birren,et al.  Campomelic dysplasia translocation breakpoints are scattered over 1 Mb proximal to SOX9: evidence for an extended control region. , 1999, American journal of human genetics.

[34]  S. Toksvig-Larsen,et al.  Rearrangement of the neoplasia‐associated gene HMGIC in synovia from patients with osteoarthritis , 1999, Genes, chromosomes & cancer.

[35]  W. V. D. Van de Ven,et al.  HMGI-C rearrangements as the molecular basis for the majority of pulmonary chondroid hamartomas: a survey of 30 tumors. , 1996, Oncogene.

[36]  K. Chada,et al.  Misexpression of disrupted HMGI architectural factors activates alternative pathways of tumorigenesis. , 1997, Cancer research.

[37]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .